WILKINS INVESTMENT COUNSEL INC - Q3 2020 holdings

$335 Million is the total value of WILKINS INVESTMENT COUNSEL INC's 74 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 18.2% .

 Value Shares↓ Weighting
NEM BuyNewmont$23,467,000
+3.4%
369,850
+0.6%
7.00%
-2.6%
MRK BuyMerck$16,868,000
+7.9%
203,357
+0.6%
5.03%
+1.6%
INTC BuyIntel$13,561,000
-9.6%
261,897
+4.5%
4.04%
-14.8%
JNJ BuyJohnson & Johnson$11,409,000
+6.3%
76,634
+0.4%
3.40%
+0.1%
NVS BuyNovartis AG (ADR)$10,998,000
+1.7%
126,470
+2.1%
3.28%
-4.2%
IFF BuyInternational Flavors & Fragra$10,622,000
+4.9%
86,747
+4.9%
3.17%
-1.2%
ADP BuyAutomatic Data Processing$10,034,000
+1.2%
71,931
+8.0%
2.99%
-4.7%
MDT BuyMedtronic PLC$9,768,000
+14.2%
93,995
+0.8%
2.91%
+7.6%
NTRS BuyNorthern Trust$8,653,000
-1.6%
110,982
+0.1%
2.58%
-7.4%
MMM Buy3M$8,488,000
+3.1%
52,991
+0.4%
2.53%
-2.8%
FFIV BuyF5 Networks$8,036,000
-6.0%
65,455
+6.8%
2.40%
-11.5%
CB BuyChubb Limited$7,815,000
-5.4%
67,304
+3.2%
2.33%
-10.9%
HSY BuyHershey Company$7,269,000
+10.9%
50,714
+0.2%
2.17%
+4.4%
CTVA BuyCorteva$6,516,000
+32.3%
226,161
+23.0%
1.94%
+24.6%
AZPN BuyAspen Technology$5,967,000
+46.2%
47,135
+19.6%
1.78%
+37.7%
BP BuyBP PLC$5,669,000
-16.5%
324,703
+11.5%
1.69%
-21.4%
WMB BuyWilliams Cos$5,284,000
+14.8%
268,925
+11.1%
1.58%
+8.1%
CL BuyColgate Palmolive$5,068,000
+7.5%
65,690
+2.0%
1.51%
+1.2%
SLB BuySchlumberger$4,717,000
-13.3%
303,150
+2.5%
1.41%
-18.4%
CERN BuyCerner Corp$3,001,000
+7.0%
41,520
+1.5%
0.90%
+0.8%
FTNT BuyFortinet$966,000
+1.6%
8,200
+18.4%
0.29%
-4.3%
JPM BuyJ.P. Morgan Chase$759,000
+58.8%
7,880
+55.1%
0.23%
+49.7%
ES NewEversource Energy$292,0003,500
+100.0%
0.09%
SWK NewStanley Black & Decker, Inc.$243,0001,500
+100.0%
0.07%
ORCL NewOracle$215,0003,600
+100.0%
0.06%
AAPL NewApple Computer$208,0001,800
+100.0%
0.06%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Merck42Q3 20235.7%
Newmont Mining42Q3 20237.2%
Procter & Gamble42Q3 20234.9%
Intel42Q3 20235.0%
Johnson & Johnson42Q3 20233.7%
International Flavors & Fragra42Q3 20234.2%
Automatic Data Processing42Q3 20233.9%
Sysco42Q3 20234.2%
Northern Trust42Q3 20234.0%
Novartis AG (ADR)42Q3 20233.7%

View WILKINS INVESTMENT COUNSEL INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-11-09
13F-HR2023-08-07
13F-HR2023-05-08
13F-HR2023-02-07
13F-HR2022-11-08
13F-HR2022-08-08
13F-HR2022-05-10
13F-HR2022-02-10
13F-HR2021-11-09

View WILKINS INVESTMENT COUNSEL INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (335389000.0 != 335387000.0)

Export WILKINS INVESTMENT COUNSEL INC's holdings